FierceBiotech – Enyo Pharma gets a $24M funding boost for hep B cure candidate

http://www.fiercebiotech.com/story/enyo-pharma-gets-24m-funding-boost-hep-b-cure-candidate/2016-02-03

Published on 03/02/2016

Les Echos – Enyo Pharma décroche 22 millions contre l’hépatite B

http://www.lesechos.fr/idees-debats/sciences-prospective/021657131735-enyo-pharma-decroche-22-millions-contre-lhepatite-b-1197233.php

Published on 03/02/2016

ENYO Pharma announces closing of a €22 million funding round

Lyon, February 3, 2016 – ENYO Pharma announces closing of a €22 million funding round.

Read more »

Published on 03/02/2016

AVIESAN – Kick-off Meeting REACTing

29-30 June 2015

Les Pensières” Fondation Mérieux-Conference Center, Veyrier du Lac – France

REsearch and ACTion targeting emerging infectious diseases (REACTing)

Dr V. Lotteau’s talk : “Response to Ebola : In vitro & in vivo experiments”

Read more »

Published on 01/02/2016

Biotuesday, march 2015

3 March 2015

Lyon, France

Dr Jacky Vonderscher’s talk : “Présentations sur les atouts des petites molécules en Santé humaine”

http://biotuesday.fr/biotuesday2009/editions-2015/mars-2015/

Read more »

Published on 29/01/2016